EVMN R&D Expenses
Evommune, Inc. Common Stock · R&D Expenses
EVMN R&D Expenses
Latest reported$26.41Mperiod ending
EVMN Quarterly R&D Expenses ($7.95M → $26.41M)
Quarterly R&D Expenses
High-resolution chart · PNG
EVMN r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 26,412,000 | |
| 17,319,000 | |
| 20,403,000 | |
| 19,639,000 | |
| 19,638,000 | |
| 14,362,000 | |
| 15,559,500 | |
| 13,289,000 | |
| 25,178,000 | |
| 7,947,000 |